Skip to search formSkip to main contentSkip to account menu

dofetilide

Known as: Dofetilida, 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane, beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide 
A sulfonamide class III antiarrhythmic agent and potassium channel blocker. Dofetilide selectively blocks cardiac ion channels of the rapid component… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Assessing the proarrhythmic potential of compounds during drug development is essential. However, reliable prediction of drug… 
Highly Cited
2003
Highly Cited
2003
Introduction: Reliable detection of drug‐induced proarrhythmia, especially the potential for polymorphic ventricular tachycardia… 
Highly Cited
1997
Highly Cited
1997
A variety of class III antiarrhythmic agents have been shown to block the delayed rectifier current, but their effects on other K… 
Highly Cited
1997
Highly Cited
1997
Two characteristic features of the rapid component of the cardiac delayed rectifier current (IKr) are prominent inward… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND The objective of this study was to assess the influence of heart rate on QT-interval duration and dispersion during…